138 results
8-K
EX-3.1
MYMD
MyMD Pharmaceuticals Inc
8 Apr 24
Entry into a Material Definitive Agreement
4:49pm
.
Change in Nature of Business. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, engage … been enacted.
Taxes. The Company and its Subsidiaries shall pay when due all taxes, fees or other charges of any nature whatsoever (together with any
8-K
EX-3.1
MYMD
MyMD Pharmaceuticals Inc
7 Mar 24
Entry into a Material Definitive Agreement
4:30pm
or accelerate prior to the Maturity Date.
C-25
(g) Change in Nature of Business. The Company shall not, and the Company shall cause each of its Subsidiaries … due all taxes, fees or other charges of any nature whatsoever (together with any related interest or penalties) now or hereafter imposed or assessed
8-K
EX-99.1
1521744fmrs157h
12 Apr 23
Regulation FD Disclosure
8:45am
D
o3dtpb54aqzfkpxts
30 Aug 22
$7.41M in options / securities to be acquired, 8 investors
8:00am
8-K
EX-99.1
1wokmqr
21 Jun 22
Regulation FD Disclosure
10:30am
8-K
EX-99.1
e1u nj84q6yr
23 Feb 22
Regulation FD Disclosure
12:02pm
8-K
EX-99.1
848pgi8p80n
8 Feb 22
MyMD Pharmaceuticals Announces Positive Clinical Data in Advance of Upcoming Phase 2 Trial of MYMD-1 for Extending Healthy Lifespan
9:20am